Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Grimm

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Pathogens (Basel, Switzerland)|February 25, 2023
Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic ReviewCassandra Mah, Thisun Jayawardana, Gary Leong, et al.
Scientific Reports|December 3, 2016
Genome analysis of Campylobacter concisus strains from patients with inflammatory bowel disease and gastroenteritis provides new insights into pathogenicityHeung Kit Leslie Chung, Alfred Tay, Sophie Octavia, et al.
Plos One|June 6, 2012
Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel diseaseYazan Ismail, Vikneswari Mahendran, Sophie Octavia, et al.
Frontiers in Physiology|August 22, 2017
<i>Campylobacter concisus</i> Genomospecies 2 Is Better Adapted to the Human Gastrointestinal Tract as Compared with <i>Campylobacter concisus</i> Genomospecies 1Yiming Wang, Fang Liu, Xiang Zhang, et al.
Emerging Microbes & Infections|April 12, 2018
Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn's diseaseFang Liu, Rena Ma, Chin Yen Alfred Tay, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Pathogens (Basel, Switzerland)|February 25, 2023
Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic ReviewCassandra Mah, Thisun Jayawardana, Gary Leong, et al.
Scientific Reports|December 3, 2016
Genome analysis of Campylobacter concisus strains from patients with inflammatory bowel disease and gastroenteritis provides new insights into pathogenicityHeung Kit Leslie Chung, Alfred Tay, Sophie Octavia, et al.
Plos One|June 6, 2012
Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel diseaseYazan Ismail, Vikneswari Mahendran, Sophie Octavia, et al.
Frontiers in Physiology|August 22, 2017
<i>Campylobacter concisus</i> Genomospecies 2 Is Better Adapted to the Human Gastrointestinal Tract as Compared with <i>Campylobacter concisus</i> Genomospecies 1Yiming Wang, Fang Liu, Xiang Zhang, et al.
Emerging Microbes & Infections|April 12, 2018
Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn's diseaseFang Liu, Rena Ma, Chin Yen Alfred Tay, et al.
Pageof 4